Industry Portals

Biotechnical Industry News

Integer a velit nec risus malesuada imperdiet id et odio. Nunc sit amet mauris dapibus, feugiat diam eget, suscipit, nam gravida nulla eget turpis commodo.

Young & Partners Pharmaceutical Executive Summit 2024: The Impact of Artificial Intelligence on the Creation of Medicines (Pharmaceutical Executive)

October 24th, 2024|Featured, Our Publications|

Pharmaceutical Executive shares Fred Hassan's and Najat Khan's comments made at the 2024 Young & Partners Pharmaceutical Executive Summit. https://www.pharmexec.com/view/young-partners-pharmaceutical-executive-summit-2024-impact-artificial-intelligence-creation-medicines

Young & Partners 2024 Pharmaceutical Executive Summit: Speakers Roundtable- What Does the Future Hold

October 23rd, 2024|Our Broadcasts|

Michael Christel, Global Editor, MJH Life Sciences; Fred Hassan, Director, Warburg Pincus; Najat Khan, Chief R&D and Commercial Officer, Recursion; Doug Long, Vice President, Industry Relations, IQVIA; Peter Marks, M.D., Director, Center of Biologics Evaluation and Research, U.S. Food and Drug Administration; Dr. Stephen P. Spielberg, M.D. PhD, Senior Adviser, Young & Partners, former Deputy Commissioner for Medical Products and Tobacco, U.S. Food and Drug Administration; Sandy Zweifach, President and CBO, IMIDomics; Peter Young, CEO and President, Young & Partners

Industry Restructuring & Inorganic Growth Through an Era of Chronic Oversupply (World Chemical Forum Speech September 10, 2024)

September 10th, 2024|Featured, Our Publications|

Young & Partners shares their thoughts and analysis of the global oversupply and uncertainties that have impacted the chemical markets. The presentation addresses the era of chronic oversupply, strategic assessments, M&A market conditions, and Strategic and M&A alternatives.